证券记录 · 已归档季度
UFPT
UFP Technologies, Inc. · Healthcare · Medical - Devices
10被追踪持有人
—Δ持有人
642.12K持有股份
$169.45M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 84 | 0 | 5.60M | $1.48B | +5 | −5 |
| Q1 2026 | 87 | -2 | 5.05M | $977.88M | +5 | −7 |
| Q4 2025 | 89 | -3 | 5.34M | $1.19B | — | −3 |
| Q3 2025 | 18 | 0 | 2.83M | $564.24M | — | — |
| Q2 2025 | 15 | +2 | 2.67M | $652.20M | +2 | — |
| Q1 2025 | 10 | -1 | 1.10M | $222.08M | +1 | −2 |
| Q4 2024 | 11 | 0 | 1.06M | $258.43M | +1 | −1 |
| Q3 2024 | 10 | 0 | 609.62K | $193.08M | +1 | −1 |
| Q2 2024 | 10 | — | 642.12K | $169.45M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 293.61K | — | $77.48M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 169.66K | — | $44.78M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 169.66K | — | $44.78M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 106.83K | — | $28.19M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 106.83K | — | $28.19M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 26.71K | — | $7.05M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 20.19K | — | $5.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 20.19K | — | $5.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 20.19K | — | $5.33M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 9.14K | — | $2.41M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 9.14K | — | $2.41M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 7.29K | — | $1.92M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 7.29K | — | $1.92M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 5.97K | — | $1.58M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.87K | — | $493,965 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 835 | — | $220,331 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 271 持有人, 8.76M 股份, $1.58B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 18
Hudson Symeria
Director · 298 股 · $95,095
Aug 14
Hudson Symeria
Director · 1.93K 股 · $625,141
Aug 13
FELDMANN CYNTHIA L
Director · 1.00K 股 · $324,260
Aug 10
BAILLY R JEFFREY
Officer, Director · 6.87K 股 · $2.17M
Aug 10
BAILLY R JEFFREY
Officer, Director · 5.77K 股 · $1.82M
Aug 10
BAILLY R JEFFREY
Officer, Director · 374 股 · $118,659
Aug 07
BAILLY R JEFFREY
Officer, Director · 542 股 · $170,763
Aug 07
BAILLY R JEFFREY
Officer, Director · 4.47K 股 · $1.42M
Aug 06
BAILLY R JEFFREY
Officer, Director · 7.88K 股 · $2.51M
Aug 06
BAILLY R JEFFREY
Officer, Director · 2.81K 股 · $897,740
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 31
SC 13G — VANGUARD CAPITAL MANAGEMENT LLC
Jul 17
SC 13G/A — WASATCH ADVISORS LP
Jul 07
SC 13G — Neuberger Berman Group LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据